1. DOP38 Upadacitinib Therapy Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy. (30th January 2023) Authors: Colombel, J F; Hisamatsu, T; Bresso, F; Thin, L; Parra, R; Ford, S; Remple, V; Lacerda, A P; Hecht, P; Mallick, M; Garrison, A; Regueiro, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P434 Upadacitinib improved fatigue and health-related quality of life in patients with moderately to severely active Crohn's disease: Results from induction and maintenance phase 3 trials. (30th January 2023) Authors: Ghosh, S; Feagan, B; Parra, R S; Lopes, S; Steinlauf, A; Kakuta, Y; Joshi, N; Lee, W J; Remple, V; Lacerda, A P; Zhou, Q; Xuan, S; Louis, E Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P439 Induction of endoscopic response, remission and ulcer-free endoscopy with upadacitinib is associated with improved quality of life in patients with Crohn's disease. (30th January 2023) Authors: Panés, J; Louis, E; Bossuyt, P; Joshi, N; Lee, W J; Lacerda, A; Remple, V; Xuan, S; Loftus Jr., E V Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P506 Endoscopic and clinical outcomes of upadacitinib in patients with moderate to severe Crohn's disease by baseline disease severity. (30th January 2023) Authors: Siegmund, B; Patel, K; Torres, E A; Lakatos, P L; Seidelin, J; Fleisher, M; Ford, S; Remple, V; Lacerda, A P; Anyanwu, S; Garrison, A; Panés, J Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P786 Induction of endoscopic response, remission and ulcer-free endoscopy with upadacitinib is associated with improved clinical outcomes in patients with Crohn's disease. (30th January 2023) Authors: Panés, J; Louis, E; Bossuyt, P; Joshi, N; Lee, W J; Lacerda, A; Remple, V; Xuan, S; Loftus Jr., E V Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0378 Impact of the adalimumab patient support program on clinical outcomes in ankylosing spondylitis: results from the companion study. (15th June 2017) Authors: Bessette, L; Thorne, C; Millson, B; Charland, K; Donepudi, K; Gaetano, T; Remple, V; Latour, M; Laliberté, M-C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗